CYCLO THERAPEUTICS, INC.

Profile

Company Names

CYCLO THERAPEUTICS, INC.
CTD HOLDINGS INC

Addresses

6714 NW 16TH STREET, SUITE B, GAINSVILLE, FL 32653

6714 NW 16TH STREET, SUITE B, GAINESVILLE, FL 32653

6714 NW 16TH STREET, SUITE B, GAINESVILLE, FL 32563

14120 NW 126TH TERRACE, ALACHUA, FL 32615-4816

Phone Numbers

386-418-8060

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

FLORIDA

Total Amount Raised:

$25,088,218.00

Number of Funding Rounds:

12
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
12
2020-08-27 
$2,831,114.00 
$3,000,000.00 
$168,886.00 
Equity 
11
2020-04-24 
$2,000,000.00 
$2,000,000.00 
$0.00 
Equity 
10
2019-05-31 
$7,442,500.00 
$7,442,500.00 
$0.00 
Equity 
9
2018-12-21 
$2,125,413.00 
$5,000,000.00 
$2,874,587.00 
Equity 
8
2017-10-18 
$1,500,000.00 
$5,000,000.00 
$3,500,000.00 
Equity 
7
2017-02-23 
$2,014,191.00 
$2,014,191.00 
$0.00 
Equity 
6
2016-06-07 
$2,000,000.00 
$2,000,000.00 
$0.00 
Equity 
5
2015-08-20 
$650,000.00 
$650,000.00 
$0.00 
Equity 
4
2015-07-10 
$1,300,000.00 
$1,300,000.00 
$0.00 
Equity 
3
2014-07-21 
$1,725,000.00 
$1,725,000.00 
$0.00 
Equity 
2
2014-04-09 
$1,000,000.00 
$1,000,000.00 
$0.00 
Equity 
1
2014-02-19 
$500,000.00 
$500,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GEORGE 
 
FAILS 
DIRECTOR
GEORGE 
L. 
FAILS 
DIRECTOR, EXECUTIVE OFFICER
JOSEPH (JUDGE) 
J. 
FARNAN 
DIRECTOR
JOSHUA 
 
FINE 
EXECUTIVE OFFICER
N. 
SCOTT 
FINE 
DIRECTOR
NATHAN 
SCOTT 
FINE 
EXECUTIVE OFFICER, DIRECTOR
F. 
PATRICK 
OSTRONIC 
DIRECTOR
FRANCIS 
PATRICK 
OSTRONIC 
DIRECTOR
MARKUS 
 
SEIGER 
DIRECTOR
MARKUS 
W. 
SEIGER 
DIRECTOR
WILLIAM 
S. 
SHANAHAN 
DIRECTOR
MARKUS 
 
SIEGER 
DIRECTOR
MARKUS 
W. 
SIEGER 
DIRECTOR
C. E. 
RICK 
STRATTAN 
EXECUTIVE OFFICER, DIRECTOR
C.E. 
RICK 
STRATTAN 
DIRECTOR
JEFFREY 
L. 
TATE 
EXECUTIVE OFFICER, DIRECTOR
RANDALL 
M. 
TOIG 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
INDUSTRIAL ORGANIC CHEMICALS [2860] 
DECLINE TO DISCLOSE 
Equity 
2020-08-27 
D
BIOTECHNOLOGY 
INDUSTRIAL ORGANIC CHEMICALS [2860] 
DECLINE TO DISCLOSE 
Equity 
2020-04-24 
D
BIOTECHNOLOGY 
INDUSTRIAL ORGANIC CHEMICALS [2860] 
DECLINE TO DISCLOSE 
Equity 
2019-05-31 
D
BIOTECHNOLOGY 
INDUSTRIAL ORGANIC CHEMICALS [2860] 
DECLINE TO DISCLOSE 
Equity 
2018-12-21 
D
BIOTECHNOLOGY 
INDUSTRIAL ORGANIC CHEMICALS [2860] 
DECLINE TO DISCLOSE 
Equity 
2017-10-18 
D
BIOTECHNOLOGY 
INDUSTRIAL ORGANIC CHEMICALS [2860] 
DECLINE TO DISCLOSE 
Equity 
2017-02-23 
D
BIOTECHNOLOGY 
INDUSTRIAL ORGANIC CHEMICALS [2860] 
DECLINE TO DISCLOSE 
Equity 
2016-06-07 
D
BIOTECHNOLOGY 
INDUSTRIAL ORGANIC CHEMICALS [2860] 
DECLINE TO DISCLOSE 
Equity 
2015-08-20 
D
BIOTECHNOLOGY 
INDUSTRIAL ORGANIC CHEMICALS [2860] 
DECLINE TO DISCLOSE 
Equity 
2015-07-10 
D
BIOTECHNOLOGY 
INDUSTRIAL ORGANIC CHEMICALS [2860] 
DECLINE TO DISCLOSE 
Equity 
2014-07-21 
D
BIOTECHNOLOGY 
INDUSTRIAL ORGANIC CHEMICALS [2860] 
DECLINE TO DISCLOSE 
Equity 
2014-04-09 
D
BIOTECHNOLOGY 
INDUSTRIAL ORGANIC CHEMICALS [2860] 
DECLINE TO DISCLOSE 
Equity 
2014-02-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
FORDHAM FINANCIAL MANAGEMENT, INC.
NONE
NONE
SCARSDALE EQUITIES LLC
NONE
NONE
SCARSDALE EQUITIES LLC
NONE
NONE
SCARSDALE EQUITIES LLC